Home » Authors » Glen Harris

Articles by Glen Harris

Rigel Shares Skyrocket 224% With Success Of RA Drug

Dec. 14, 2007

Savient's Gout Drug Puricase Hits Endpoints In Dual Trials

Dec. 14, 2007

Competition For Few Compounds Drives Up Deal Costs, Complexity

Nov. 14, 2007

As Big Pharma Model Falters, Biotech Rides To The Rescue

Nov. 14, 2007

As Big Pharma Model Falters, Biotech Rides To The Rescue

Nov. 14, 2007

Competition For Few Compounds Drives Up Deal Costs, Complexity

Nov. 14, 2007

As Big Pharma Model Falters, Biotech Rides To The Rescue

Nov. 13, 2007

As Big Pharma Model Falters, Biotech Rides To The Rescue

Nov. 13, 2007

Targanta IPO Nets $59.9M To Advance Oritavancin

Oct. 11, 2007

Targanta IPO Nets $59.9M To Advance Oritavancin

Oct. 11, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...